Table 5.
Progression data at 2-years of follow-up in the study groups
Site of reccurence / progression | Combined organ-sparing management | Radical nephroureterectomy | Statistical evaluation |
---|---|---|---|
Upper tract reccurence | 3 (9%) | – | χ2 = 1.65; р = 0.79 |
Bladder reccurence | 3 (9%) | 5 (15%) | |
Nodal metastases | 4 (12%) | 5 (15%) | |
Distant metastases | 3 (9%) | 4 (12%) | |
UTUC-associated death | 3 (9%) | 4 (12%) |
UTUC – upper tract urothelial cancer